Insulin glargine and lixisenatide and Posaconazole Injection
Determining the interaction of Insulin glargine and lixisenatide and Posaconazole Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Posaconazole Intravenous
- Insulin glargine and lixisenatide-Posaconazole Oral Suspension
- Insulin glargine and lixisenatide-Posaconazole oral/injection
- Insulin glargine and lixisenatide-Posaconazole Tablets
- Insulin glargine and lixisenatide-PosiFlush flush
- Insulin glargine and lixisenatide-Positive Skin Test Control - Histamine
- Posaconazole Injection-Insulin glargine and lixisenatide Subcutaneous
- Posaconazole Injection-Insulin glargine, recombinant Subcutaneous
- Posaconazole Injection-Insulin glulisine
- Posaconazole Injection-Insulin Glulisine (Cartridges and Pens)
- Posaconazole Injection-Insulin Glulisine (Vials)
- Posaconazole Injection-Insulin glulisine Subcutaneous